Clinical Trial Update: CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update describes cytoreductive surgery for kidney cancer combined with immunotherapy and targeted kinase inhibition, with the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Renal Cell Carcinoma

Snippet

Sponsor: Mark Stein | Conditions: Kidney Cancer, Renal Cell Carcinoma | Phase 2 | Status: RECRUITING